Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Statement to an Insufficient Systematic Review on Viscum album L. Therapy.
Matthes H, Thronicke A, Hofheinz RD, Baars E, Martin D, Huber R, Breitkreuz T, Bar-Sela G, Galun D, Schad F. Matthes H, et al. Among authors: hofheinz rd. Evid Based Complement Alternat Med. 2020 Feb 18;2020:7091039. doi: 10.1155/2020/7091039. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32148549 Free PMC article.
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.
Hofheinz RD, Anchisi S, Grünberger B, Derigs HG, Zahn MO, Geffriaud-Ricouard C, Gueldner M, Windemuth-Kieselbach C, Pederiva S, Bohanes P, Scholten F, Piringer G, Thaler J, von Moos R. Hofheinz RD, et al. Cancers (Basel). 2022 Jul 20;14(14):3522. doi: 10.3390/cancers14143522. Cancers (Basel). 2022. PMID: 35884583 Free PMC article.
Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis.
Hohneck AL, Sadikaj L, Heinemann L, Schroeder M, Riess H, Gerhards A, Burkholder I, Heckel-Reusser S, Gottfried J, Hofheinz RD. Hohneck AL, et al. Among authors: hofheinz rd. Cancers (Basel). 2023 Oct 11;15(20):4929. doi: 10.3390/cancers15204929. Cancers (Basel). 2023. PMID: 37894296 Free PMC article.
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited.
Diefenhardt M, Schlenska-Lange A, Kuhnt T, Kirste S, Piso P, Bechstein WO, Hildebrandt G, Ghadimi M, Hofheinz RD, Rödel C, Fokas E; German Rectal Cancer Study Group. Diefenhardt M, et al. Among authors: hofheinz rd. Cancers (Basel). 2022 Jul 27;14(15):3658. doi: 10.3390/cancers14153658. Cancers (Basel). 2022. PMID: 35954320 Free PMC article.
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.
Diefenhardt M, Martin D, Ludmir EB, Fleischmann M, Hofheinz RD, Ghadimi M, Kosmala R, Polat B, Friede T, Minsky BD, Rödel C, Fokas E. Diefenhardt M, et al. Among authors: hofheinz rd. Cancers (Basel). 2022 Sep 12;14(18):4425. doi: 10.3390/cancers14184425. Cancers (Basel). 2022. PMID: 36139585 Free PMC article.
216 results